Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
Despite global vaccination efforts, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve and spread globally. Relatively high vaccination rates have been achieved in most regions of the United States and several countries worldwide. However, access to vaccines in low- and...
Guardado en:
Autores principales: | Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Hisaaki Kawabata, Dominika Bielak, Weina Sun, Irene González-Domínguez, D Noah Sather, Adolfo García-Sastre, Peter Palese, Florian Krammer, Juan Manuel Carreño |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b32844202bb44e5b26127bad0eeb6d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Working Safely with H5N1 Viruses
por: Adolfo García-Sastre
Publicado: (2012) -
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Fatima Amanat, et al.
Publicado: (2021) -
Riesgo de introducción de la enfermedad de Newcastle a Chile por la importación de avestruces
por: Burbano,L. A., et al.
Publicado: (2005) -
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.
por: Zsuzsanna T Varga, et al.
Publicado: (2011) -
The Pause on Avian H5N1 Influenza Virus Transmission Research Should Be Ended
por: Ron A. M. Fouchier, et al.
Publicado: (2012)